Skip to main content

Health prediction markets

48 health market groups in the catalog. A group may contain related contracts with different settlement rules.

Market data updated . Prices are snapshots. The catalog refreshes every three hours.

Showing 1-48 of 48 event groups

Ranked within each platform by reported lifetime volume. Polymarket reports dollars; Kalshi reports contracts.

PolymarketKalshiHealth
Next pandemic

Next pandemic

PM $21.78M · K 1.16M contracts

Hantavirus pandemic in 2026?

Kalshi: Pandemic by Dec 31, 2027?

Related contracts

PM Yes 1.1%Rules differK Yes 15.5%

New pandemic in 2026?

Kalshi: Pandemic by Dec 31, 2027?

Related contracts

PM Yes 1.6%Rules differK Yes 15.5%

New pandemic in 2026?

Kalshi: New pandemic by 2026?

Related contracts

PM Yes 1.6%Rules differK Yes 1.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

9 saved comparisonsNext deadline Jan 1, 2027 UTC
KalshiScience and Technology
Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?

Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?

K 2.05M contracts
Hantavirus Public Health Emergency of International Concern by 2026?Yes 1.7%
1 mktNext deadline Jan 1, 2027 UTC
KalshiScience and Technology
Will the FDA approve any psychedelic substance for medical use this year?

Will the FDA approve any psychedelic substance for medical use this year?

K 447.2K contracts
Will the FDA approve Any psychedelic substance for medical use this year?Yes 19%
1 mktNext deadline Jan 8, 2027 UTC
PolymarketKalshiScience
Will the FDA approve retatrutide?

Will the FDA approve retatrutide?

PM $599.1K · K 119.1K contracts

FDA approves Retatrutide this year?

Kalshi: When will the FDA approve retatrutide (LY3437943)? (Before Jan 1, 2027)

Related contracts

PM Yes 1.6%Rules differK Yes 1.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

1 saved comparisonNext deadline Jan 1, 2027 UTC
KalshiPolitics
What will the average number of measles cases be during Trump's term?

What will the average number of measles cases be during Trump's term?

K 94.1K contracts
What will the average number of measles cases be during the Trump Administration? (At least 2000)Yes 97.5%
What will the average number of measles cases be during the Trump Administration? (At least 3000)Yes 97%
What will the average number of measles cases be during the Trump Administration? (At least 2500)Yes 96.5%
+4 moreNext deadline Jan 1, 2029 UTC
PolymarketHealth
Hantavirus vaccine in 2026?

Hantavirus vaccine in 2026?

PM $156.0K
Hantavirus vaccine in 2026? Yes 1.8%
1 mktNext deadline Jan 1, 2027 UTC
PolymarketKalshiCulture
Which countries will report an Ebola case in 2026?

Which countries will report an Ebola case in 2026?

PM $82.8K · K 490.9K contracts

Will South Sudan have an Ebola case in 2026?

Kalshi: Will a human case of Ebola disease in South Sudan be reported before Jan 1, 2027?

Same question, fine print differs

PM Yes 24%Rules differK Yes 33.5%

Will Ethiopia have an Ebola case in 2026?

Kalshi: Will a human case of Ebola disease in Ethiopia be reported before Jan 1, 2027?

Same question, fine print differs

PM Yes 18%Rules differK Yes 14.5%

Will India have an Ebola case in 2026?

Kalshi: Will a human case of Ebola disease in India be reported before Jan 1, 2027?

Same question, fine print differs

PM Yes 16%Rules differK Yes 7.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

10 saved comparisonsNext deadline Jan 1, 2027 UTC
KalshiHealth
Will NYC subway ridership reach its pre-Covid average?

Will NYC subway ridership reach its pre-Covid average?

K 71.3K contracts
Will NYC subway ridership reach 90% of the pre-Covid average before Jan 1, 2027?Yes 29%
Will NYC subway ridership reach 100% of the pre-Covid average before Jan 1, 2027?Yes 2.5%
2 mktsNext deadline Jan 1, 2027 UTC
PolymarketKalshiPolitics
When will Heidi Overton be confirmed as Commissioner of the FDA?

When will Heidi Overton be confirmed as Commissioner of the FDA?

PM $43.4K · K 50.4K contracts

Will Heidi Overton be confirmed as FDA Commissioner by November 30?

Kalshi: Will Heidi Overton be confirmed as Commissioner of the Food and Drug Administration before Dec 1, 2026?

Same question, fine print differs

PM Yes 0.8%Rules differK Yes 0.5%

Will Heidi Overton be confirmed as FDA Commissioner by December 31?

Kalshi: Will Heidi Overton be confirmed as Commissioner of the Food and Drug Administration before Jan 1, 2027?

Same question, fine print differs

PM Yes 0.5%Rules differK Yes 0.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

2 saved comparisonsNext deadline Dec 1, 2026 UTC
KalshiEconomics
Will New Jersey pharmaceutical manufacturing jobs rise YoY?

Will New Jersey pharmaceutical manufacturing jobs rise YoY?

K 63.1K contracts
Will New Jersey’s annual-average employment in Pharmaceutical and Medicine Manufacturing for 2026 be above 30,300 jobs?Yes 5.5%
1 mktNext deadline May 7, 2027 UTC
KalshiHealth
Will there be a year without polio before 2030?

Will there be a year without polio before 2030?

K 43.0K contracts
Will there be a year with zero wild polio cases before 2030?Yes 5.9%
1 mktNext deadline Jan 1, 2030 UTC
PolymarketHealth
Plague case in US by December 31?

Plague case in US by December 31?

PM $18.8K
Plague case in US by December 31?Yes 2.3%
1 mktNext deadline Jan 1, 2027 UTC
PolymarketKalshiHealth
When will the FDA reclassify BPC-157 to Category 1?

When will the FDA reclassify BPC-157 to Category 1?

PM $5.7K · K 33.3K contracts

Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?

Kalshi: When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?

Related contracts

PM Yes 4.5%Rules differK Yes 4.5%

Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.

Saved prices; check contract rules.

1 saved comparisonNext deadline Jan 1, 2027 UTC
KalshiHealth
Hims subscribers in 2026

Hims subscribers in 2026

K 42.4K contracts
Will Hims & Hers Health Inc. report Above 2.8 million subscribers in 2026?Yes 75.5%
Will Hims & Hers Health Inc. report Above 2.68 million subscribers in fiscal 2026?Yes 75%
Will Hims & Hers Health Inc. report Above 2.72 million subscribers in fiscal 2026?Yes 63%
+11 moreNext deadline Mar 31, 2028 UTC
KalshiHealth
Will Trump make IVF free?

Will Trump make IVF free?

K 38.3K contracts
Will Trump make IVF free?Yes 13.5%
1 mktNext deadline Jan 27, 2029 UTC
KalshiEconomics
Will Minnesota medical-device manufacturing jobs rise YoY?

Will Minnesota medical-device manufacturing jobs rise YoY?

K 37.8K contracts
Will Minnesota’s annual-average employment in Medical Equipment and Supplies Manufacturing for 2026 be above 18,200 jobs?Yes 97.5%
1 mktNext deadline May 7, 2027 UTC
KalshiPolitics
Who will leave office first: RFK Jr., Hegseth, or Patel?

Who will leave office first: RFK Jr., Hegseth, or Patel?

K 36.8K contracts
Will Secretary of Defense be the first to leave office?Yes 48.5%
Will Secretary of Health and Human Services be the first to leave office?Yes 38.5%
Will Director of the Federal Bureau of Investigation be the first to leave office?Yes 16.5%
3 mktsNext deadline Jan 20, 2029 UTC
KalshiPolitics
What will JD Vance say during NYT DealBook Summit?

What will JD Vance say during NYT DealBook Summit?

K 33.3K contracts
What will JD Vance say during 2026 New York Times DealBook Summit originally scheduled for November 18, 2026? (Democrat)Yes 88%
What will JD Vance say during 2026 New York Times DealBook Summit originally scheduled for November 18, 2026? (Economy / Economic)Yes 87.5%
What will JD Vance say during 2026 New York Times DealBook Summit originally scheduled for November 18, 2026? (Iran / Iranian)Yes 86%
+17 moreNext deadline Dec 2, 2026 UTC
KalshiEconomics
Will North Carolina pharmaceutical manufacturing jobs rise YoY?

Will North Carolina pharmaceutical manufacturing jobs rise YoY?

K 28.6K contracts
Will North Carolina’s employment in Pharmaceutical and Medicine Manufacturing for December 2026 be above 26,500 jobs?Yes 23%
1 mktNext deadline Apr 7, 2027 UTC
KalshiHealth
When will the FDA approve Compass Pathways' COMP360 Psilocybin?

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

K 27.5K contracts
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028)Yes 90%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027)Yes 87.5%
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027)Yes 83%
+2 moreNext deadline Jan 8, 2027 UTC
KalshiWorld
What sector will Anthropic be assigned to?

What sector will Anthropic be assigned to?

K 27.3K contracts
Will Anthropic be assigned to Information Technology?Yes 98.5%
Will Anthropic be assigned to Unassigned?Yes 3%
Will Anthropic be assigned to Communication Services?Yes 2%
+9 moreNext deadline Jan 18, 2028 UTC
KalshiHealth
How many tuberculosis cases will be reported in the United States in 2026?

How many tuberculosis cases will be reported in the United States in 2026?

K 22.0K contracts
Above 7000 tuberculosis disease cases in the United States during 2026Yes 95.5%
Above 8000 tuberculosis disease cases in the United States during 2026Yes 91%
Above 9000 tuberculosis disease cases in the United States during 2026Yes 70.5%
+2 moreNext deadline Jan 8, 2027 UTC
KalshiHealth
When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

K 21.8K contracts
Will CMS announce the addition of GLP-1 drugs for obesity to Part D before Jan 20, 2029?Yes 48.5%
Will CMS announce the addition of GLP-1 drugs for obesity to Part D before Jan 1, 2028?Yes 46.5%
Will CMS announce the addition of GLP-1 drugs for obesity to Part D before Jan 1, 2027?Yes 4.5%
3 mktsNext deadline Jan 8, 2027 UTC
KalshiHealth
When will Compass Pathways submit a NDA for COMP360 psilocybin?

When will Compass Pathways submit a NDA for COMP360 psilocybin?

K 17.5K contracts
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before 2027)Yes 98.5%
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before April 2027)Yes 98.5%
When will COMPASS Pathways plc submit a NDA for COMP360 psilocybin to the FDA? (before December)Yes 96.5%
3 mktsNext deadline Dec 8, 2026 UTC
KalshiHealth
Will there be a case of polio in the USA this year?

Will there be a case of polio in the USA this year?

K 16.4K contracts
Will there be a case of polio in the USA this year?Yes 3.5%
1 mktNext deadline Jan 31, 2027 UTC
KalshiHealth
Will the FDA approve MDMA for PTSD?

Will the FDA approve MDMA for PTSD?

K 13.7K contracts
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2031?Yes 53.5%
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2030?Yes 52.5%
Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2032?Yes 51.5%
+3 moreNext deadline Jan 8, 2027 UTC
KalshiHealth
When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

K 11.0K contracts
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? (before April 2027)Yes 84%
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? (before 2027)Yes 49%
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? (before December)Yes 8%
3 mktsNext deadline Dec 8, 2026 UTC
KalshiHealth
Will the FDA approve a cure for Type 1 diabetes before 2033?

Will the FDA approve a cure for Type 1 diabetes before 2033?

K 10.9K contracts
Will the FDA approve a cure for Type 1 Diabetes before 2033?Yes 38.5%
1 mktNext deadline Jan 8, 2033 UTC
KalshiHealth
Which vaccines will the CDC no longer recommend in 2026?

Which vaccines will the CDC no longer recommend in 2026?

K 10.1K contracts
Will the CDC end its recommendation for the COVID-19 vaccine?Yes 8.8%
Will the CDC end its recommendation for the Influenza vaccine?Yes 6.9%
Will the CDC end its recommendation for the Hepatitis B vaccine?Yes 4.8%
+3 moreNext deadline Jan 1, 2027 UTC
KalshiHealth
Will the FDA approve CagriSema?

Will the FDA approve CagriSema?

K 7.1K contracts
Will the FDA approve CagriSema before Jan 1, 2028?Yes 92.5%
Will the FDA approve CagriSema before Jul 1, 2027?Yes 90.5%
Will the FDA approve CagriSema before Jan 1, 2027?Yes 89.5%
3 mktsNext deadline Jan 8, 2027 UTC
KalshiFinancials
Companies added to the MSCI USA Index in Q4?

Companies added to the MSCI USA Index in Q4?

K 6.6K contracts
Will X-energy be added to the MSCI USA Index in Q4 2026?Yes 49.5%
Will US Foods be added to the MSCI USA Index in Q4 2026?Yes 35%
Will Woodward be added to the MSCI USA Index in Q4 2026?Yes 23.5%
+5 moreNext deadline Jan 7, 2027 UTC
KalshiHealth
When will the FDA approve Intellia Therapeutics' lonvo-z?

When will the FDA approve Intellia Therapeutics' lonvo-z?

K 6.6K contracts
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? (Before October 2027)Yes 92%
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? (Before 2028)Yes 90.5%
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema? (Before July 2027)Yes 89%
3 mktsNext deadline Jul 8, 2027 UTC
KalshiHealth
Hims subscribers in Q1 2027

Hims subscribers in Q1 2027

K 5.2K contracts
Will Hims & Hers Health, Inc. report Above 2.7 million subscribers in Q1 2027?Yes 87.5%
Will Hims & Hers Health, Inc. report Above 2.8 million subscribers in Q1 2027?Yes 73.5%
Will Hims & Hers Health, Inc. report Above 2.9 million subscribers in Q1 2027?Yes 45.5%
+3 moreNext deadline Sep 7, 2027 UTC
KalshiHealth
Will the FDA approve cytisinicline for smoking cessation?

Will the FDA approve cytisinicline for smoking cessation?

K 4.3K contracts
Will the FDA approve cytisinicline for smoking cessation before Jul 1, 2027?Yes 47.5%
Will the FDA approve cytisinicline for smoking cessation before Jan 1, 2027?Yes 6%
2 mktsNext deadline Jan 8, 2027 UTC
KalshiFinancials
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)

FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)

K 4.2K contracts
What will the FDA's decision be on Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences in 2026?Yes 88.5%
1 mktNext deadline Jan 8, 2027 UTC
KalshiHealth
Will the FDA approve intismeran autogene (V940/mRNA-4157)?

Will the FDA approve intismeran autogene (V940/mRNA-4157)?

K 3.1K contracts
Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Jul 1, 2028?Yes 95%
Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Jan 1, 2028?Yes 85.5%
Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Oct 1, 2027?Yes 67%
+2 moreNext deadline Apr 8, 2027 UTC
KalshiHealth
Will the FDA approve VERVE-102?

Will the FDA approve VERVE-102?

K 1.8K contracts
Will the FDA approve VERVE-102 before Jan 1, 2035?Yes 83%
Will the FDA approve VERVE-102 before Jan 1, 2034?Yes 77%
Will the FDA approve VERVE-102 before Jan 1, 2033?Yes 75%
+3 moreNext deadline Jan 8, 2030 UTC
KalshiFinancials
FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)

FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)

K 1.7K contracts
What will the FDA's decision be on Saroglitazar by Zydus Therapeutics in 2026?Yes 77.5%
1 mktNext deadline Jan 8, 2027 UTC
KalshiFinancials
FDA decision: Venglustat by Sanofi (in 2026)

FDA decision: Venglustat by Sanofi (in 2026)

K 1.0K contracts
What will the FDA's decision be on Venglustat by Sanofi in 2026?Yes 81.5%
1 mktNext deadline Jan 8, 2027 UTC
KalshiFinancials
FDA decision: BBP-418 by Ml Bio Solutions Inc. (in 2026)

FDA decision: BBP-418 by Ml Bio Solutions Inc. (in 2026)

K 944.1 contracts
What will the FDA's decision be on BBP-418 by Ml Bio Solutions Inc. in 2026?Yes 89%
1 mktNext deadline Jan 8, 2027 UTC
KalshiScience and Technology
Will the FDA approve any psychedelic substance for medical use before 2028?

Will the FDA approve any psychedelic substance for medical use before 2028?

K 471.5 contracts
Will the FDA approve any psychedelic substance for medical use before 2028?Yes 78%
1 mktNext deadline Jan 8, 2028 UTC
KalshiFinancials
FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)

FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)

K 308.93 contracts
What will the FDA's decision be on Tozorakimab by AstraZeneca on or before March 31, 2027?Yes 76%
1 mktNext deadline Apr 8, 2027 UTC
KalshiFinancials
FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)

FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)

K 70.02 contracts
What will the FDA's decision be on Lorundrostat by Mineralys Therapeutics on or before December 22, 2026?Yes 83%
1 mktNext deadline Dec 30, 2026 UTC
KalshiFinancials
FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

K 41.42 contracts
What will the FDA's decision be on Ralinepag by United Therapeutics on or before June 24, 2027?Yes 79%
1 mktNext deadline Jul 2, 2027 UTC
KalshiHealth
US employer health insurance cost growth in Q4 2026

US employer health insurance cost growth in Q4 2026

K 22.27 contracts
Will the YoY increase in U.S. private-industry employer health-benefit costs for December 2026 be above 4.5%?Yes 95.5%
Will the YoY increase in U.S. private-industry employer health-benefit costs for December 2026 be above 5.0%?Yes 93.5%
Will the YoY increase in U.S. private-industry employer health-benefit costs for December 2026 be above 5.5%?Yes 86.5%
+4 moreNext deadline Feb 5, 2027 UTC
KalshiFinancials
FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)

FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)

K 12.94 contracts
What will the FDA's decision be on Ulixacaltamide by Praxis Precision Medicines on or before January 29, 2027?Yes 72.5%
1 mktNext deadline Feb 6, 2027 UTC
KalshiHealth
BrightSpring Health prescriptions filled in Q1

BrightSpring Health prescriptions filled in Q1

K 0 contracts
Will BrightSpring Health Services, Inc. report Above 10.8 million prescriptions filled in Q1 2027?Yes 76%
Will BrightSpring Health Services, Inc. report Above 10.85 million prescriptions filled in Q1 2027?Yes 62%
Will BrightSpring Health Services, Inc. report Above 10.9 million prescriptions filled in Q1 2027?Yes 47%
+1 moreNext deadline Nov 28, 2027 UTC
KalshiHealth
US employer health insurance cost growth (YoY) · September 2027

US employer health insurance cost growth (YoY) · September 2027

K 0 contracts
Will year-over-year growth in U.S. employer health insurance costs for September 2027 be above 4%?Yes 96.5%
Will year-over-year growth in U.S. employer health insurance costs for September 2027 be above 5%?Yes 95%
Will year-over-year growth in U.S. employer health insurance costs for September 2027 be above 6%?Yes 90%
+4 moreNext deadline Nov 5, 2027 UTC